Inventor
LACROIX-FRALISH MICHAEL L
US11 patents
⚠️ This page may combine multiple inventors who share the name “LACROIX-FRALISH MICHAEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
7 patentsUS10285388B2May 14, 2019
Non-human animals having a disruption in a C9ORF72 locus
REGENERON PHARMA2 citations70
US9028819B2May 12, 2015
Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2
REGENERON PHARMA1 citations61
US11547101B2Jan 10, 2023
Non-human animals having a disruption in a C9ORF72 locus
REGENERON PHARMA0 citations59
US10513557B2Dec 24, 2019
Anti-ASIC1 antibodies and uses thereof
REGENERON PHARMA0 citations51
US9951132B2Apr 24, 2018
Anti-prokineticin receptor (PROKR) antibodies and uses thereof
REGENERON PHARMA0 citations51
US9371383B2Jun 21, 2016
Anti-ASIC1 antibodies and uses thereof
REGENERON PHARMA1 citations51
US9150648B2Oct 6, 2015
Anti-ASIC1 antibodies and uses thereof
REGENERON PHARMA0 citations51
MACDONALD LYNN
3 patentsUS8425907B2Apr 23, 2013
Methods for treating pruritus by administering an antibody that specifically binds human PAR2
MACDONALD LYNN14 citations91
US8101724B2Jan 24, 2012
High-affinity human antibodies to human protease-activated receptor-2
MACDONALD LYNN10 citations82
US8871996B2Oct 28, 2014
Mice expressing human voltage-gated sodium channels
MACDONALD LYNN3 citations61